Early type I IFN blockade improves the efficacy of viral vaccines

J Exp Med. 2020 Dec 7;217(12):e20191220. doi: 10.1084/jem.20191220.

Abstract

Type I interferons (IFN-I) are a major antiviral defense and are critical for the activation of the adaptive immune system. However, early viral clearance by IFN-I could limit antigen availability, which could in turn impinge upon the priming of the adaptive immune system. In this study, we hypothesized that transient IFN-I blockade could increase antigen presentation after acute viral infection. To test this hypothesis, we infected mice with viruses coadministered with a single dose of IFN-I receptor-blocking antibody to induce a short-term blockade of the IFN-I pathway. This resulted in a transient "spike" in antigen levels, followed by rapid antigen clearance. Interestingly, short-term IFN-I blockade after coronavirus, flavivirus, rhabdovirus, or arenavirus infection induced a long-lasting enhancement of immunological memory that conferred improved protection upon subsequent reinfections. Short-term IFN-I blockade also improved the efficacy of viral vaccines. These findings demonstrate a novel mechanism by which IFN-I regulate immunological memory and provide insights for rational vaccine design.

MeSH terms

  • Animals
  • Antibodies, Blocking / immunology
  • Antibodies, Blocking / pharmacology
  • Antibodies, Viral / immunology
  • Antigen Presentation / immunology
  • CD8-Positive T-Lymphocytes / metabolism
  • Dendritic Cells / immunology
  • Disease Models, Animal
  • Gene Expression / immunology
  • HEK293 Cells
  • Humans
  • Immunogenicity, Vaccine / immunology*
  • Immunologic Memory
  • Interferon Type I / antagonists & inhibitors*
  • Interferon-alpha / genetics
  • Interferon-alpha / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptor, Interferon alpha-beta / genetics
  • Receptor, Interferon alpha-beta / immunology*
  • Transfection
  • Viral Vaccines / immunology*
  • Zika Virus / immunology*
  • Zika Virus Infection / immunology*
  • Zika Virus Infection / virology

Substances

  • Antibodies, Blocking
  • Antibodies, Viral
  • Ifna2 protein, mouse
  • Ifnar1 protein, mouse
  • Interferon Type I
  • Interferon-alpha
  • Viral Vaccines
  • Receptor, Interferon alpha-beta